Appendix B: Panel Roster and Financial Disclosures
Syphilis
Member | Institution | Financial Disclosure | |
---|---|---|---|
Company | Relationship | ||
Laura Bachmann | Centers for Disease Control and Prevention | None | N/A |
Khalil Ghanem | The Johns Hopkins University School of Medicine | None | N/A |
Matthew Hamill | The Johns Hopkins University School of Medicine | Chembio Diagnostics, Inc. | Honoraria |
Cepheid Chembio Diagnostics, Inc. Roche Diagnostics | Other | ||
Edward W. Hook | University of Alabama at Birmingham Marnix E. Heersink School of Medicine | Visby Medical | Scientific Advisory Board |
Arlene Sena | University of North Carolina at Chapel Hill School of Medicine | None | N/A |
Irene Stafford | The University of Texas Health Science Center at Houston, McGovern Medical School | None | N/A |
Susan Tuddenham* | The Johns Hopkins University School of Medicine | None | N/A |
Kimberly Workowski | Emory University School of Medicine | None | N/A |
* Section Group Lead Note: Members are required to update disclosures annually and to notify guideline staff of any relevant changes in status during the interim. |
Download Guidelines
- Section Only PDF (17.93 KB)
- Full Guideline PDF (6.01 MB)
- Tables Only PDF (1.13 MB)